Bone-Protecting Agents Reduce Fracture Risk During Prostate Cancer Treatment
Men with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) who are being treated with radium-223 (Xofigo) plus enzalutamide... Read More
Dietary Supplement May Derive Benefit in Prostate Cancer, Larger Studies are Warranted
Use of a dietary supplement, PectaSol (modified citrus pectin) has shown continued benefit among men with prostate cancer, according to... Read More
Radiation After Surgery May Not Be Necessary Among Men With Prostate Cancer
Men with prostate cancer could be spared having to undergo radiation after surgery given that a recent study found no... Read More